Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2021-01-16
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health
NCT04768244
Antibody Detection of Vaccine-Induced Secretory Effects
NCT04895475
Gestational Immunity for Transfer
NCT04802278
Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1c
NCT05004740
COVID-19 and Lactating Mothers
NCT04558320
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaccinations
SARS-CoV-2 vaccination
Covid vaccines
women within Priority groups for coronavirus (COVID-19) vaccination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Covid vaccines
women within Priority groups for coronavirus (COVID-19) vaccination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Clínico Universitario de Valencia
OTHER
Hospital Sant Joan de Deu
OTHER
Hospital Universitario La Fe
OTHER
Hospital Universitario Doctor Peset
OTHER
Fundacion Para La Investigacion Hospital La Fe
OTHER
Universitat Jaume I
OTHER
University of Barcelona
OTHER
Institute of Agrochemistry and Food Technology, National Research Council
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Carmen Collado
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundacion Investigacion Sanitaria INCLIVA
Valencia, , Spain
Hospital Universitario y Politecnico la Fe
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Selma-Royo M, Bauerl C, Mena-Tudela D, Aguilar-Camprubi L, Perez-Cano FJ, Parra-Llorca A, Lerin C, Martinez-Costa C, Collado MC. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study. Genome Med. 2022 Apr 21;14(1):42. doi: 10.1186/s13073-022-01043-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IATA-CSIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.